Cardioembolic Stroke
Neurology
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
DS
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Daiichi SankyoObservation
Daiichi SankyoObservation
Clinical Trials (2)
Total enrollment: 438 patients across 2 trials
Keeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic Stroke
Start: Mar 2021Est. completion: Dec 2023318 patients
N/AUnknown
Observational Study to Evaluate the Simplified-STroke REhabilitation Assessment of Movement (S-STREAM) Scale in Subjects Who Have Experienced a Nonhemorrhagic Ischemic Stroke
Start: Jan 2012Est. completion: May 2013120 patients
N/ACompleted
Related Jobs in Neurology
Director, Distribution & Services
Xenon Pharmaceuticals
Remote
13h ago
Senior Medical Science Liaison (NYC Tri-State)
Xenon Pharmaceuticals
Remote
13h ago
$208K - $234K/yr
Director of Medical Affairs
CoMind
Miami, FL
13h ago
Director of Finance
CoMind
London, UK
13h ago
Electronics Engineering Manager
CoMind
London, UK
13h ago
Director of Information Technology
Zavation Medical Products
13h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space